Bluebird, after delays, gets speedy FDA review for beta thalassemia gene therapy
November 22, 2021Despite Positive Phase II Data, Connect Derm Drug Faces Tough Market
November 22, 2021After indicating it might entertain a sale, Novartis may receive an offer from investment group EQT and the Struengmann family for its generic unit Sandoz.
